STAT+: Supreme Court rejects challenge to Medicare drug price negotiation
Stat News • 5/18/2026
Summary
The Supreme Court has rejected a challenge to Medicare drug price negotiation. This decision may complicate the remaining lawsuits from pharmaceutical firms.
Advertisement
Lindy Score Breakdown (V4.2)
2d
Age
1
Sources
from cluster
54
Hours Since Seen
Final Score6/100
CategoryAntiLindy
StatusActive
Recency Multiplier46% (0.5^54/48)
Hero EligibleYes
Score BreakdownRisk 65
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 2 day(s) old - still early
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more
Stat News • 1 day ago
STAT+: U.K. advocacy groups threaten court action over a key provision in the pharma trade deal with the U.S.
Stat News • 2 days ago
STAT+: Senate Democrats propose adding long-term care benefit to Medicare
Stat News • Today
STAT+: A new ranking of pharma companies by R&D performance
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more
Stat News • Today
STAT+: The China question is tearing biotech apart
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more
Stat News • 2 days ago
STAT+: Maryland state affordability board places a price cap on Ozempic
Stat News • 1 day ago
STAT+: OpenEvidence makes its pitch to hospitals. ‘We’re not crazy monsters’
Stat News • Today
STAT+: NIH behind in filling top roles, with 15 of 27 institutes led by acting directors
Stat News • Today
